Oksana Malanchuk - Оксана Маланчук
Oksana Malanchuk - Оксана Маланчук
Подтвержден адрес электронной почты в домене imbg.org.ua - Главная страница
Название
Процитировано
Процитировано
Год
Protein CoAlation: a redox-regulated protein modification by coenzyme A in mammalian cells
Y Tsuchiya, SY Peak-Chew, C Newell, S Miller-Aidoo, S Mangal, ...
Biochemical Journal 474 (14), 2489-2508, 2017
352017
Protein CoAlation and antioxidant function of coenzyme A in prokaryotic cells
Y Tsuchiya, A Zhyvoloup, J Baković, N Thomas, BYK Yu, S Das, C Orengo, ...
Biochemical Journal 475 (11), 1909-1937, 2018
202018
Monoclonal antibodies to Ki-67 protein suitable for immunohistochemical analysis
A Khoruzhenko, V Kukharchuk, O Cherednyk, I Tykhonkova, ...
Hybridoma 29 (4), 301-304, 2010
122010
Generation and characterization of monoclonal antibodies specific to Coenzyme A
OM Malanchuk, GG Panasyuk, NM Serbyn, IT Gout, VV Filonenko
Вiopolymers and Cell, 2015
92015
Identification of novel binding partners for tuberous sclerosis complex 2 (TSC2) by yeast two-hybrid approach
OM Malanchuk, V Pozur, GG Panasyuk, IO Nemazanyy, VV Filonenko, ...
Exp. Oncol 27, 186-190, 2005
92005
Physical activity interferes with the immunomodulatory effect of the antineoplastic drug NSC631570
L M Skivka, O G Fedorchuk, Y M Susak, M Y Susak, O M Malanchuk, ...
Current Pharmaceutical Biotechnology 16 (1), 49-59, 2015
82015
Interaction of serine/threonine protein phosphatase 5 with the protein products of tumour suppressor gene Tsc2
OM Malanchuk, SS Palchevskyy, VK Pozur, IT Gout, VV Filonenko
Biopolymers and Cell 23 (4), 318-323, 2007
82007
The effect of antineoplastic drug NSC631570 on immunogenicity of B16 melanoma
LM Skivka, OG Fedorchuk, NO Bezdeneznykh, OO Lykhova, NI Semesiuk, ...
J Exp Integr Med 4 (2), 93-105, 2014
62014
Dephosphorylation of tuberous sclerosis complex 2 by serine/threonine protein phosphatase 5
OM Malanchuk, SS Palchevskyy, VV Filonenko
Biopolymers and cell 24 (2), 176, 2008
62008
Generation and characterization of monoclonal antibodies against tuberous sclerosis complex 2
O Malanchuk, S Palchevskyy, G Ovcharenko, J Gwalter, V Pozur, I Gout, ...
Hybridoma 26 (4), 259-266, 2007
52007
Development of monoclonal antibody against protein Rictor, a component of the mTORC2 complex
OM Malanchuk
Вiopolymers and Cell, 2015
32015
Structure and bactericidal properties of polymer composites derived from melamine-formaldehyde polymer and silver nanoparticles formed in situ
AL Tolstov, VF Matyushov, ON Malanchuk
Theoretical and Experimental Chemistry 50 (3), 181-186, 2014
32014
Generation of monoclonal antibodies specific to ribosomal protein S6 kinase 1
LO Savinska, OM Klipa, NO Demchuk, GV Ovcharenko, OM Malanchuk, ...
Вiopolymers and Cell, 2012
32012
Bactericidal polymeric composites based on poly(vinil butyral) and silver ions containing organically modified SiO2
AL Tolstov, VF Matyushov, EV Lebedev, ON Malanchuk, DA Klimchuk
Dopovyidyi Natsyional&apos, 74-80, 2016
2016
Association of Rictor with chromosomes during mitosis in MCF7 cells
OM Malanchuk
Biopolymers and cell, 422-428, 2015
2015
Novel mTOR isoform and tumorigenesis: TUE-175
O Malanchuk, S Palchevskyy, O Garifulin, V Filonenko
The Febs Journal 281, 491-492, 2014
2014
Novel mTOR isoform and tumorigenesis
O Malanchuk, S Palchevskyy, O Garifulin, V Filonenko
FEBS JOURNAL 281, 490-491, 2014
2014
Generation of monoclonal antibody against protein phosphatase 5
OM Malanchuk, GV Ovcharenko, IO Tykhonkova, OS Khoma, UV Chorna, ...
Biopolymers and cell, 136-142, 2013
2013
Novel phosphatase for tumor suppressor TSC2?: YSF. 66
O Malanchuk, S Palchevskyy, V Filonenko
The Febs Journal 278, 2011
2011
TSC2/PP5 interaction: novel phosphatase for tumor suppressor?: B2. 23
O Malanchuk, S Palchevskyy, I Gout, V Filonenko
The Febs Journal 277, 125-126, 2010
2010
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20